Clinical trials recruiting in Can Tho, Vietnam
10
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 7Not applicable 3
Conditions recruiting in Can Tho, Vietnam
Recruiting trials in Can Tho, Vietnam
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)
- Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Telemedicine Education for Caregivers and Asthma Control in Children
Common questions
How many clinical trials are recruiting in Can Tho, Vietnam?
10 recruiting trials have at least one study site in Can Tho, Vietnam.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.